1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (493)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5598)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5598)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emerging therapeutic targets in follicular lymphoma [Interview]
    Miscellaneous

    Wendel, H. G.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • Reprogramming of pluripotency-specific microRNA signatures is not essential to generate inducible pluripotent stem cells
    Correspondence

    Skamagki, M.; Zhang, C.; Liu, Z.; Li, H.; Zhao, R.; Kim, K.
    Cellular Reprogramming (2020)

    Fulltext@MSK | Save
  • Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry
    Journal Article

    Thoren, K. L.; Eveillard, M.; Chan, P.; Doddi, S.; Cho, S.; Murata, K.
    Clinical Biochemistry (2020)

    Fulltext@MSK | Save
  • Structure–function insights into the initial step of DNA integration by a CRISPR–Cas–transposon complex
    Research Letter

    Jia, N.; Xie, W.; de la Cruz, M. J.; Eng, E. T.; Patel, D. J.
    Cell Research (2020)

    Fulltext@MSK | Save
  • A p53-independent DNA damage response suppresses oncogenic proliferation and genome instability
    Journal Article

    Fagan-Solis, K. D.; Simpson, D. A.; Kumar, R. J.; Martelotto, L. G.; Mose, L. E.; Rashid, N. U.; Ho, A. Y.; Powell, S. N.; Wen, Y. H.; Parker, J. S.; more...
    Cell Reports (2020)

    Fulltext@MSK | Save
  • KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures
    Review

    Friedlaender, A.; Drilon, A.; Weiss, G. J.; Banna, G. L.; Addeo, A.
    Cancer Treatment Reviews (2020)

    Fulltext@MSK | Save
  • Preoperative assessment of upper extremity secondary lymphedema
    Journal Article

    Wiser, I.; Mehrara, B. J.; Coriddi, M.; Kenworthy, E.; Cavalli, M.; Encarnacion, E.; Dayan, J. H.
    Cancers (2020)

    Fulltext@MSK | Save
  • Patient-derived xenograft models in urological malignancies: Urothelial cell carcinoma and renal cell carcinoma
    Review

    Tracey, A. T.; Murray, K. S.; Coleman, J. A.; Kim, K.
    Cancers (2020)

    Fulltext@MSK | Save
  • Therapeuticstargeting the gut microbiome: Rigorous pipelines for drug development
    Editorial

    Markey, K. A.; van den Brink, M. R. M.; Peled, J. U.
    Cell Host & Microbe (2020)

    Fulltext@MSK | Save
  • Gain-of-function mutant p53 R273H interacts with replicating DNA and PARP1 in breast cancer
    Journal Article

    Xiao, G.; Lundine, D.; Annor, G. K.; Canar, J.; Ellison, V.; Polotskaia, A.; Donabedian, P. L.; Reiner, T.; Khramtsova, G. F.; Olopade, O. I.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save